CVD

Medical Events

Contact us to enquire about advertising your events.

Dr Khaled Mohamed Aly
Dr Khaled Mohamed Aly
Dr Khaled Mohamed Aly is a medical specialist MBBCH; M.S.C Cairo University; ACLS -EP; ATLS-SL (South Africa) Critical care course program-USA Disastrous medicine; STEMI-certificate AHA Hospital management and infection control diplomas Cairo University. Author of Critical Care Professional Handbook. Dr Khalad is Head of CME in Egypt for MEMP Ltd.
Dr Khaled Mohamed Aly
Dr Khaled Mohamed Aly
Dr Khaled Mohamed Aly
Dr Khaled Mohamed Aly is a medical specialist MBBCH; M.S.C Cairo University; ACLS -EP; ATLS-SL (South Africa) Critical care course program-USA Disastrous medicine; STEMI-certificate AHA Hospital management and infection control diplomas Cairo University. Author of Critical Care Professional Handbook. Dr Khalad is Head of CME in Egypt for MEMP Ltd.

Hypertensive emergencies

An approach to understanding hypertensive emergencies written by Dr Khaled Mohamed of International SOS.

Continue reading
Dr Marwan Elbagoury
Dr Marwan Elbagoury
Marwan is an Alexandria University, Pharmacy graduate (2006), MBA from Cambridge KIPP (2015), Bachelor of Law graduate (2018), M.Sc. of Advanced Oncology (2018). He has over ten years experience in multinational biotechnology companies and has twelve scientific papers published.
Dr Marwan Elbagoury
Dr Marwan Elbagoury
Dr Marwan Elbagoury
Marwan is an Alexandria University, Pharmacy graduate (2006), MBA from Cambridge KIPP (2015), Bachelor of Law graduate (2018), M.Sc. of Advanced Oncology (2018). He has over ten years experience in multinational biotechnology companies and has twelve scientific papers published.

The treatment of obesity and CVD

The expansion of obesity has increased dramatically around the world. Obesity is defined as excessive storage of energy in the form of fats.1 It is one of the most common nutritional disorder in developing countries. The World Health Organization (WHO) declared that obesity has become a global health problem, which can lead to a variety of serious conditions. In addition

Continue reading

View references

1.     Hill O., J. NIH Public Access. Circulation 126, 126–132 (2012).

2.      Figure, S. No Title No Title_2015. 1–4 doi:10.15713/ins.mmj.3

3.     Lavie, C. J. & Milani, R. V. Obesity and cardiovascular disease: The Hippocrates paradox? J. Am. Coll. Cardiol. 42, 677–679 (2003).

4.     Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937–952 (2004).

Subscribe to our mailing list

Overlay